The clinical outcome after coronary bypass surgery: a 30-year follow-up study

Ron T van Domburg1, Arie Pieter Kappetein, Ad J J C Bogers

  • 1Thoraxcenter, Erasmus Medical Centre, Rotterdam, The Netherlands. r.vandomburg@erasmusmc.nl

European Heart Journal
|December 11, 2008
PubMed

Insights

This 30-year study shows coronary artery bypass graft (CABG) surgery offers a median life expectancy of 17.6 years. However, most patients require repeat interventions, indicating CABG is a palliative treatment for progressive coronary artery disease.

Area of Science:

  • Cardiovascular Surgery
  • Clinical Outcomes Research
  • Long-term Patient Follow-up

Background:

  • Coronary artery bypass graft (CABG) surgery is a common intervention for coronary artery disease.
  • Understanding the long-term clinical outcomes and life expectancy (LE) after CABG is crucial for patient management.
  • Previous studies have provided insights, but extended follow-up data up to 30 years is less common.

Purpose of the Study:

  • To investigate the long-term clinical outcomes up to 30 years following coronary artery bypass graft (CABG) surgery.
  • To assess the life expectancy (LE) of patients after CABG, analyzing subgroups based on disease severity and cardiac function.
  • To evaluate the need for repeat revascularization procedures over three decades post-CABG.

Main Methods:

  • Analysis of 30-year outcomes for 1041 patients undergoing venous CABG between 1971 and 1980.
  • Comprehensive follow-up every 5-7 years, including hospital records, general practitioners, and civil registries.
  • Kaplan-Meier curves used to determine cumulative survival, freedom from re-intervention, and overall life expectancy.

Main Results:

  • 30-year survival rates were 77% at 10 years, 40% at 20 years, and 15% at 30 years.
  • Overall median life expectancy after first CABG was 17.6 years, varying by extent of vessel disease and left ventricular ejection fraction.
  • A high rate of repeat interventions was observed, with 36% of patients undergoing 623 coronary re-interventions by 30 years.

Conclusions:

  • The 30-year follow-up provides a near-complete life cycle assessment after CABG.
  • Venous CABG is a useful palliative treatment for progressive coronary artery disease, but not a definitive cure.
  • Factors such as age, extent of vessel disease, and left ventricular ejection fraction significantly impact long-term mortality and life expectancy.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
627
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
637